Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089590172> ?p ?o ?g. }
- W3089590172 endingPage "2824" @default.
- W3089590172 startingPage "2824" @default.
- W3089590172 abstract "Glycosylation patterns commonly change in cancer, resulting in expression of tumor-associated carbohydrate antigens (TACA). While promising, currently available anti-glycan antibodies are not useful for clinical cancer therapy. Here, we show that potent anti-glycan antibodies can be engineered to acquire cancer therapeutic efficacy. We designed yeast surface display to generate and select for therapeutic antibodies against the TACA SLea (CA19−9) in colon and pancreatic cancers. Elite clones showed increased affinity, better specificity, improved binding of human pancreatic and colon cancer cell lines, and increased complement-dependent therapeutic efficacy. Molecular modeling explained the structural basis for improved antibody functionality at the molecular level. These new tools of directed molecular evolution and selection for effective anti-glycan antibodies, provide insights into the mechanisms of cancer therapy targeting glycosylation, and provide major methodological advances that are likely to open up innovative avenues of research in the field of cancer theranostics." @default.
- W3089590172 created "2020-10-08" @default.
- W3089590172 creator A5000429785 @default.
- W3089590172 creator A5006003266 @default.
- W3089590172 creator A5018882725 @default.
- W3089590172 creator A5020487629 @default.
- W3089590172 creator A5023852817 @default.
- W3089590172 creator A5031748920 @default.
- W3089590172 creator A5040145749 @default.
- W3089590172 creator A5049437339 @default.
- W3089590172 creator A5063223548 @default.
- W3089590172 creator A5070293727 @default.
- W3089590172 creator A5086719622 @default.
- W3089590172 creator A5088677743 @default.
- W3089590172 creator A5089889621 @default.
- W3089590172 date "2020-09-30" @default.
- W3089590172 modified "2023-09-24" @default.
- W3089590172 title "Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer" @default.
- W3089590172 cites W1182461782 @default.
- W3089590172 cites W1825978543 @default.
- W3089590172 cites W1902656581 @default.
- W3089590172 cites W1963658052 @default.
- W3089590172 cites W1969995412 @default.
- W3089590172 cites W1978130850 @default.
- W3089590172 cites W1983124068 @default.
- W3089590172 cites W1989427609 @default.
- W3089590172 cites W1997668120 @default.
- W3089590172 cites W2003150414 @default.
- W3089590172 cites W2018295245 @default.
- W3089590172 cites W2018448767 @default.
- W3089590172 cites W2018453381 @default.
- W3089590172 cites W2021164895 @default.
- W3089590172 cites W2029667189 @default.
- W3089590172 cites W2037073184 @default.
- W3089590172 cites W2039484130 @default.
- W3089590172 cites W2044835625 @default.
- W3089590172 cites W2046404274 @default.
- W3089590172 cites W2058194911 @default.
- W3089590172 cites W2059529313 @default.
- W3089590172 cites W2065770795 @default.
- W3089590172 cites W2071099979 @default.
- W3089590172 cites W2071379789 @default.
- W3089590172 cites W2072120389 @default.
- W3089590172 cites W2075828698 @default.
- W3089590172 cites W2077058827 @default.
- W3089590172 cites W2078837657 @default.
- W3089590172 cites W2086239639 @default.
- W3089590172 cites W2087502238 @default.
- W3089590172 cites W2087596773 @default.
- W3089590172 cites W2090522870 @default.
- W3089590172 cites W2101744248 @default.
- W3089590172 cites W2104290364 @default.
- W3089590172 cites W2107160157 @default.
- W3089590172 cites W2107409328 @default.
- W3089590172 cites W2109844644 @default.
- W3089590172 cites W2113229974 @default.
- W3089590172 cites W2120323942 @default.
- W3089590172 cites W2123250052 @default.
- W3089590172 cites W2123708888 @default.
- W3089590172 cites W2125748493 @default.
- W3089590172 cites W2132629607 @default.
- W3089590172 cites W2136482421 @default.
- W3089590172 cites W2142731071 @default.
- W3089590172 cites W2150323743 @default.
- W3089590172 cites W2151759421 @default.
- W3089590172 cites W2153206534 @default.
- W3089590172 cites W2155181356 @default.
- W3089590172 cites W2156402312 @default.
- W3089590172 cites W2162561057 @default.
- W3089590172 cites W2172766517 @default.
- W3089590172 cites W2297905809 @default.
- W3089590172 cites W2332712348 @default.
- W3089590172 cites W2403210488 @default.
- W3089590172 cites W2404280981 @default.
- W3089590172 cites W2405465892 @default.
- W3089590172 cites W2408662284 @default.
- W3089590172 cites W2427197815 @default.
- W3089590172 cites W2590096149 @default.
- W3089590172 cites W2801559979 @default.
- W3089590172 cites W2803441813 @default.
- W3089590172 cites W2832495826 @default.
- W3089590172 cites W2896148359 @default.
- W3089590172 cites W2902841742 @default.
- W3089590172 cites W3080182702 @default.
- W3089590172 cites W653375350 @default.
- W3089590172 doi "https://doi.org/10.3390/cancers12102824" @default.
- W3089590172 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7601599" @default.
- W3089590172 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33007970" @default.
- W3089590172 hasPublicationYear "2020" @default.
- W3089590172 type Work @default.
- W3089590172 sameAs 3089590172 @default.
- W3089590172 citedByCount "13" @default.
- W3089590172 countsByYear W30895901722021 @default.
- W3089590172 countsByYear W30895901722022 @default.
- W3089590172 countsByYear W30895901722023 @default.
- W3089590172 crossrefType "journal-article" @default.
- W3089590172 hasAuthorship W3089590172A5000429785 @default.
- W3089590172 hasAuthorship W3089590172A5006003266 @default.